Nuveen Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $647K | Hold |
129,724
| – | – | ﹤0.01% | 2886 |
|
|
2024
Q3 | $699K | Hold |
129,724
| – | – | ﹤0.01% | 2896 |
|
|
2024
Q2 | $429K | Hold |
129,724
| – | – | ﹤0.01% | 3043 |
|
|
2024
Q1 | $424K | Hold |
129,724
| – | – | ﹤0.01% | 3022 |
|
|
2023
Q4 | $455K | Sell |
129,724
-56,252
| -30% | -$197K | ﹤0.01% | 3037 |
|
|
2023
Q3 | $1.24M | Buy |
185,976
+56,523
| +44% | +$378K | ﹤0.01% | 2483 |
|
|
2023
Q2 | $1.09M | Buy |
+129,453
| New | +$1.09M | ﹤0.01% | 2612 |
|
|
2022
Q2 | – | Sell |
-237,359
| Closed | -$1.14M | – | 3231 |
|
|
2022
Q1 | $1.14M | Buy |
237,359
+662
| +0.3% | +$3.17K | ﹤0.01% | 2772 |
|
|
2021
Q4 | $1.55M | Sell |
236,697
-12,238
| -5% | -$80K | ﹤0.01% | 2691 |
|
|
2021
Q3 | $2.13M | Sell |
248,935
-99,190
| -28% | -$850K | ﹤0.01% | 2644 |
|
|
2021
Q2 | $3.94M | Buy |
+348,125
| New | +$3.94M | ﹤0.01% | 2362 |
|
|
2020
Q2 | – | Sell |
-61,063
| Closed | -$151K | – | 3206 |
|
|
2020
Q1 | $151K | Sell |
61,063
-78,319
| -56% | -$194K | ﹤0.01% | 3025 |
|
|
2019
Q4 | $810K | Buy |
139,382
+64,863
| +87% | +$377K | ﹤0.01% | 2757 |
|
|
2019
Q3 | $393K | Buy |
74,519
+8,826
| +13% | +$46.5K | ﹤0.01% | 3006 |
|
|
2019
Q2 | $394K | Buy |
+65,693
| New | +$394K | ﹤0.01% | 3060 |
|